HealthcareServices

Acute Lung Injury Market Outlook 2026–2030: Key Business Drivers and Trends

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the acute lung injury market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Acute Lung Injury Market expected to grow between 2026 and 2030?

The acute lung injury market has consistently expanded in recent years. Its valuation is projected to increase from $2.59 billion in 2025 to $2.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. This historical growth can be linked to the widespread occurrence of pneumonia and trauma-induced lung injuries, restricted availability of advanced ventilation systems, increasing knowledge of critical care, the widespread use of standard fluid management protocols, and a reliance on hospital-based treatment approaches.

The acute lung injury market is anticipated to observe consistent expansion over the coming years, with its value expected to reach $3.19 billion by 2030, progressing at a compound annual growth rate (CAGR) of 4.2%. This growth during the forecast period can be attributed to the emergence of new pharmacotherapies for ALI, the increasing incorporation of AI in patient monitoring, the worldwide expansion of intensive care units, a growing embrace of personalized treatment strategies, and advancements in minimally invasive ventilation technologies. Significant trends for the forecast period include a global increase in acute lung injury cases, heightened adoption of mechanical ventilation technologies, the expanding application of pharmacotherapy and fluid management, a strong emphasis on tools for early diagnosis and monitoring, and the ongoing expansion of hospital-based critical care facilities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp

Which Drivers Are Influencing Market Acceleration In The Acute Lung Injury Market?

The escalating incidence of respiratory illnesses is anticipated to fuel the expansion of the acute lung injury market moving forward. Respiratory diseases describe a collection of ailments that impact the lungs and other components of the respiratory system, leading to breathing difficulties and impaired lung performance. The increasing occurrence of respiratory diseases can be attributed to heightened air pollution, smoking, inactive lifestyles, aging populations, and the consequences of viral infections. Conditions such as pneumonia, which are respiratory diseases, induce acute lung injury by triggering severe inflammation and damaging the alveoli, which results in compromised gas exchange and respiratory distress. For instance, in October 2024, data from the National Asthma Council, an Australia-based non-profit organization, indicated that in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, demonstrating a consistent trend in asthma mortality over the two years. Therefore, the growing prevalence of respiratory diseases is propelling the growth of the acute lung injury market.

What Leading Segments Are Studied In The Acute Lung Injury Market?

The acute lung injury market covered in this report is segmented –

1) By Injury Type: Direct Injury, Indirect Injury

2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis

Which Trends Are Expected To Influence The Acute Lung Injury Market In The Upcoming Years?

Leading companies operating in the acute lung injury treatment market are focusing on developing advanced solutions, such as recombinant human plasma gelsolin (rhu-pGSN), to address imbalanced inflammation, regulate key immune responses, and potentially enhance patient outcomes in severe lung injury cases. Recombinant human plasma gelsolin (rhu-pGSN) is derived from gelsolin, a highly conserved protein that plays a crucial role in controlling immune dysregulation observed in acute respiratory distress syndrome (ARDS). For instance, in June 2025, BioAegis Therapeutics, a US-based biotech company, obtained Fast Track designation from the U.S. Food and Drug Administration (FDA) for its leading product candidate, rhu-pGSN, intended for ARDS treatment. This therapy offers several distinct advantages, including rebalancing problematic inflammation without suppressing immune function, modulating critical immune responses in the lungs, and potentially improving results for patients with severe inflammatory lung injury.

Which Major Industry Participants Are Leading The Acute Lung Injury Market Growth?

Major companies operating in the acute lung injury market are Medtronic plc, Baxter International Inc., GE Healthcare Technologies Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Koninklijke Philips N.V., Hamilton Medical AG, Vyaire Medical Inc., Vapotherm Inc., GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Faron Pharmaceuticals Oy, Windtree Therapeutics Inc., Apeiron Biologics AG, ReAlta Life Sciences Inc., Vasomune Therapeutics Inc., MediciNova Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Acute Lung Injury Market?

North America was the largest region in the acute lung injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Acute Lung Injury Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp

Browse Through More Reports Similar to the Global Acute Lung Injury Market 2026, By The Business Research Company

Acute Spinal Cord Injury Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Acute Respiratory Distress Syndrome Ards Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795